{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T11:52:40Z","timestamp":1794397960841,"version":"4.9.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T00:00:00Z","timestamp":1646697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T00:00:00Z","timestamp":1646697600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS003033"],"award-info":[{"award-number":["NS003033"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS003034"],"award-info":[{"award-number":["NS003034"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Neurodegener"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Parkinson\u2019s disease (PD) is characterized by intra-neuronal deposition of the protein \u03b1-synuclein (\u03b1-syn) and by deficiencies of the catecholamines dopamine and norepinephrine (NE) in the brain and heart. Accumulation of \u03b1-syn in sympathetic noradrenergic nerves may provide a useful PD biomarker; however, whether \u03b1-syn buildup is pathophysiological has been unclear. If it were, one would expect associations of intra-neuronal \u03b1-syn deposition with catecholaminergic denervation and with decreased NE contents in the same samples.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We assayed immunoreactive \u03b1-syn and tyrosine hydroxylase (TH, a marker of catecholaminergic innervation) concurrently with catecholamines in coded post-mortem scalp skin, submandibular gland (SMG), and apical left ventricular myocardial tissue samples from 14 patients with autopsy-proven PD and 12 age-matched control subjects who did not have a neurodegenerative disease.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The PD group had increased \u03b1-syn in sympathetic noradrenergically innervated arrector pili muscles (5.7 times control, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001), SMG (35 times control, <jats:italic>P<\/jats:italic>\u2009=\u20090.0011), and myocardium (11 times control, <jats:italic>P<\/jats:italic>\u2009=\u20090.0011). Myocardial TH in the PD group was decreased by 65% compared to the control group (<jats:italic>P<\/jats:italic>\u2009=\u20090.0008), whereas the groups did not differ in TH in either arrector pili muscles or SMG. Similarly, myocardial NE was decreased by 92% in the PD group (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001), but the groups did not differ in NE in either scalp skin or SMG.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>PD entails increased \u03b1-syn in skin, SMG, and myocardial tissues. In skin and SMG, augmented \u03b1-syn deposition in sympathetic nerves does not seem to be pathogenic. The pathophysiological significance of intra-neuronal \u03b1-syn deposition appears to be organ-selective and prominent in the heart.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40035-022-00289-y","type":"journal-article","created":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T14:03:02Z","timestamp":1646748182000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Pathophysiological significance of increased \u03b1-synuclein deposition in sympathetic nerves in Parkinson\u2019s disease: a post-mortem observational study"],"prefix":"10.1186","volume":"11","author":[{"given":"Risa","family":"Isonaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patti","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5709-9940","authenticated-orcid":false,"given":"David S.","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,8]]},"reference":[{"issue":"6645","key":"289_CR1","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M. Alpha-synuclein in Lewy bodies. Nature. 1997;388(6645):839\u201340.","journal-title":"Nature"},{"issue":"11","key":"289_CR2","doi-asserted-by":"publisher","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","volume":"95","author":"MG Spillantini","year":"1998","unstructured":"Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M. Alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson\u2019s disease and dementia with lewy bodies. Proc Natl Acad Sci U S A. 1998;95(11):6469\u201373.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"289_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-010-0706-x","volume":"120","author":"K Wakabayashi","year":"2010","unstructured":"Wakabayashi K, Mori F, Tanji K, Orimo S, Takahashi H. Involvement of the peripheral nervous system in synucleinopathies, tauopathies and other neurodegenerative proteinopathies of the brain. Acta Neuropathol. 2010;120(1):1\u201312.","journal-title":"Acta Neuropathol"},{"issue":"6","key":"289_CR4","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s00401-010-0664-3","volume":"119","author":"TG Beach","year":"2010","unstructured":"Beach TG, Adler CH, Sue LI, Vedders L, Lue L, White Iii CL, et al. Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders. Acta Neuropathol. 2010;119(6):689\u2013702.","journal-title":"Acta Neuropathol"},{"issue":"8","key":"289_CR5","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1002\/mds.25776","volume":"29","author":"E Gelpi","year":"2014","unstructured":"Gelpi E, Navarro-Otano J, Tolosa E, Gaig C, Compta Y, Rey MJ, et al. Multiple organ involvement by alpha-synuclein pathology in Lewy body disorders. Mov Disord. 2014;29(8):1010\u20138.","journal-title":"Mov Disord"},{"issue":"6","key":"289_CR6","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s10286-018-0581-4","volume":"29","author":"V Donadio","year":"2019","unstructured":"Donadio V. Skin nerve alpha-synuclein deposits in Parkinson\u2019s disease and other synucleinopathies: a review. Clin Auton Res. 2019;29(6):577\u201385.","journal-title":"Clin Auton Res"},{"issue":"6","key":"289_CR7","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s00401-010-0665-2","volume":"119","author":"K Del Tredici","year":"2010","unstructured":"Del Tredici K, Hawkes CH, Ghebremedhin E, Braak H. Lewy pathology in the submandibular gland of individuals with incidental Lewy body disease and sporadic Parkinson\u2019s disease. Acta Neuropathol. 2010;119(6):703\u201313.","journal-title":"Acta Neuropathol"},{"issue":"28","key":"289_CR8","doi-asserted-by":"publisher","first-page":"e11337","DOI":"10.1097\/MD.0000000000011337","volume":"97","author":"F Yan","year":"2018","unstructured":"Yan F, Chen Y, Li M, Wang Y, Zhang W, Chen X, et al. Gastrointestinal nervous system alpha-synuclein as a potential biomarker of Parkinson disease. Medicine. 2018;97(28):e11337.","journal-title":"Medicine"},{"issue":"Pt 3","key":"289_CR9","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1093\/brain\/awm302","volume":"131","author":"S Orimo","year":"2008","unstructured":"Orimo S, Uchihara T, Nakamura A, Mori F, Kakita A, Wakabayashi K, et al. Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson\u2019s disease. Brain. 2008;131(Pt 3):642\u201350.","journal-title":"Brain"},{"issue":"2","key":"289_CR10","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s10286-017-0495-6","volume":"28","author":"R Isonaka","year":"2018","unstructured":"Isonaka R, Sullivan P, Jinsmaa Y, Corrales A, Goldstein DS. Spectrum of abnormalities of sympathetic tyrosine hydroxylase and alpha-synuclein in chronic autonomic failure. Clin Auton Res. 2018;28(2):223\u201330.","journal-title":"Clin Auton Res"},{"issue":"4","key":"289_CR11","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1161\/HYPERTENSIONAHA.118.12642","volume":"73","author":"R Isonaka","year":"2019","unstructured":"Isonaka R, Rosenberg AZ, Sullivan P, Corrales A, Holmes C, Sharabi Y, et al. Alpha-Synuclein deposition within sympathetic noradrenergic neurons Is associated with myocardial noradrenergic deficiency in neurogenic orthostatic hypotension. Hypertension. 2019;73(4):910\u20138.","journal-title":"Hypertension"},{"issue":"8","key":"289_CR12","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1002\/mds.21989","volume":"23","author":"H Fujishiro","year":"2008","unstructured":"Fujishiro H, Frigerio R, Burnett M, Klos KJ, Josephs KA, Delledonne A, et al. Cardiac sympathetic denervation correlates with clinical and pathologic stages of Parkinson\u2019s disease. Mov Disord. 2008;23(8):1085\u201392.","journal-title":"Mov Disord"},{"issue":"6","key":"289_CR13","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s00401-009-0596-y","volume":"118","author":"E Ghebremedhin","year":"2009","unstructured":"Ghebremedhin E, Del Tredici K, Langston JW, Braak H. Diminished tyrosine hydroxylase immunoreactivity in the cardiac conduction system and myocardium in Parkinson\u2019s disease: an anatomical study. Acta Neuropathol. 2009;118(6):777\u201384.","journal-title":"Acta Neuropathol"},{"key":"289_CR14","doi-asserted-by":"publisher","first-page":"2910","DOI":"10.1016\/S0021-9258(18)93832-9","volume":"239","author":"T Nagatsu","year":"1964","unstructured":"Nagatsu T, Levitt M, Udenfriend S. Tyrosine hydroxylase. The initial step in norepinephrine biosynthesis. J Biol Chem. 1964;239:2910\u20137.","journal-title":"J Biol Chem"},{"issue":"3","key":"289_CR15","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1002\/cne.902330303","volume":"233","author":"M Kalia","year":"1985","unstructured":"Kalia M, Fuxe K, Goldstein M. Rat medulla oblongata. II. Dopaminergic, noradrenergic (A1 and A2) and adrenergic neurons, nerve fibers, and presumptive terminal processes. J Comp Neurol. 1985;233(3):308\u201332.","journal-title":"J Comp Neurol"},{"key":"289_CR16","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/j.1750-3639.2005.tb00097.x","volume":"15","author":"T Amino","year":"2005","unstructured":"Amino T, Orimo S, Takahashi A, Uchihara T, Mizusawa H. Profound cardiac sympathetic denervation occurs in Parkinson disease. Brain Path. 2005;15:29\u201334.","journal-title":"Brain Path"},{"issue":"6","key":"289_CR17","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s00401-005-0995-7","volume":"109","author":"S Orimo","year":"2005","unstructured":"Orimo S, Amino T, Itoh Y, Takahashi A, Kojo T, Uchihara T, et al. Cardiac sympathetic denervation precedes neuronal loss in the sympathetic ganglia in Lewy body disease. Acta Neuropathol. 2005;109(6):583\u20138.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"289_CR18","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/j.1750-3639.2006.00032.x","volume":"17","author":"S Orimo","year":"2007","unstructured":"Orimo S, Takahashi A, Uchihara T, Mori F, Kakita A, Wakabayashi K, et al. Degeneration of cardiac sympathetic nerve begins in the early disease process of Parkinson\u2019s disease. Brain Pathol. 2007;17(1):24\u201330.","journal-title":"Brain Pathol"},{"key":"289_CR19","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/jnc.12766","volume":"131","author":"DS Goldstein","year":"2014","unstructured":"Goldstein DS, Sullivan P, Holmes C, Miller GW, Sharabi Y, Kopin IJ. A vesicular sequestration to oxidative deamination shift in myocardial sympathetic nerves in Parkinson disease. J Neurochem. 2014;131:219\u201328.","journal-title":"J Neurochem"},{"key":"289_CR20","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.brainres.2017.09.033","volume":"1702","author":"DS Goldstein","year":"2019","unstructured":"Goldstein DS, Sharabi Y. The heart of PD: Lewy body diseases as neurocardiologic disorders. Brain Res. 2019;1702:74\u201384.","journal-title":"Brain Res"},{"issue":"12","key":"289_CR21","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1002\/acn3.51243","volume":"7","author":"G Lamotte","year":"2020","unstructured":"Lamotte G, Holmes C, Sullivan P, Lenka A, Goldstein DS. Cardioselective peripheral noradrenergic deficiency in Lewy body synucleinopathies. Ann Clin Transl Neurol. 2020;7(12):2450\u201360.","journal-title":"Ann Clin Transl Neurol"},{"issue":"11","key":"289_CR22","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.7326\/0003-4819-135-11-200112040-00026","volume":"135","author":"DS Goldstein","year":"2001","unstructured":"Goldstein DS, Li ST, Kopin IJ. Sympathetic neurocirculatory failure in Parkinson disease: evidence for an etiologic role of alpha-synuclein. Ann Intern Med. 2001;135(11):1010\u20131.","journal-title":"Ann Intern Med"},{"issue":"Pt 4","key":"289_CR23","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1093\/brain\/awh081","volume":"127","author":"A Singleton","year":"2004","unstructured":"Singleton A, Gwinn-Hardy K, Sharabi Y, Li ST, Holmes C, Dendi R, et al. Association between cardiac denervation and parkinsonism caused by alpha-synuclein gene triplication. Brain. 2004;127(Pt 4):768\u201372.","journal-title":"Brain"},{"key":"289_CR24","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1161\/01.CIR.78.1.41","volume":"78","author":"DS Goldstein","year":"1988","unstructured":"Goldstein DS, Brush JE Jr, Eisenhofer G, Stull R, Esler M. In vivo measurement of neuronal uptake of norepinephrine in the human heart. Circulation. 1988;78:41\u20138.","journal-title":"Circulation"},{"key":"289_CR25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/0165-1838(91)90005-N","volume":"34","author":"DS Goldstein","year":"1991","unstructured":"Goldstein DS, Cannon RO, Quyyumi A, Chang P, Duncan M, Brush JE Jr, et al. Regional extraction of circulating norepinephrine, DOPA, and dihydroxyphenylglycol in humans. J Auton Nerv Sys. 1991;34:17\u201335.","journal-title":"J Auton Nerv Sys"},{"key":"289_CR26","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.cotox.2018.12.002","volume":"13","author":"BS Cagle","year":"2019","unstructured":"Cagle BS, Crawford RA, Doorn JA. Biogenic aldehyde-mediated mechanisms of toxicity in neurodegenerative disease. Curr Opin Toxicol. 2019;13:16\u201321.","journal-title":"Curr Opin Toxicol"},{"issue":"1","key":"289_CR27","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1172\/JCI130513","volume":"130","author":"SS Kang","year":"2020","unstructured":"Kang SS, Liu X, Ahn EH, Xiang J, Manfredsson FP, Yang X, et al. Norepinephrine metabolite DOPEGAL activates AEP and pathological Tau aggregation in locus coeruleus. J Clin Invest. 2020;130(1):422\u201337.","journal-title":"J Clin Invest"},{"issue":"3","key":"289_CR28","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.neures.2007.11.011","volume":"60","author":"T Amino","year":"2008","unstructured":"Amino T, Uchihara T, Tsunekawa H, Takahata K, Shimazu S, Mizusawa H, et al. Myocardial nerve fibers are preserved in MPTP-treated mice, despite cardiac sympathetic dysfunction. Neurosci Res. 2008;60(3):314\u20138.","journal-title":"Neurosci Res"},{"key":"289_CR29","first-page":"1","volume":"66","author":"DS Goldstein","year":"2020","unstructured":"Goldstein DS. \u201cSick-but-not-dead\u201d: multiple paths to catecholamine deficiency in Lewy Body diseases. Stress. 2020;66:1\u201316.","journal-title":"Stress"},{"key":"289_CR30","first-page":"66","volume":"5","author":"DS Goldstein","year":"2019","unstructured":"Goldstein DS, Pekker MJ, Eisenhofer G, Sharabi Y. Computational modeling reveals multiple abnormalities of myocardial noradrenergic function in Lewy body diseases. JCI Insight. 2019;5:66.","journal-title":"JCI Insight"},{"issue":"23","key":"289_CR31","doi-asserted-by":"publisher","first-page":"10289","DOI":"10.1523\/JNEUROSCI.19-23-10289.1999","volume":"19","author":"DM Kuhn","year":"1999","unstructured":"Kuhn DM, Aretha CW, Geddes TJ. Peroxynitrite inactivation of tyrosine hydroxylase: mediation by sulfhydryl oxidation, not tyrosine nitration. J Neurosci. 1999;19(23):10289\u201394.","journal-title":"J Neurosci"},{"issue":"1","key":"289_CR32","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1124\/jpet.118.248492","volume":"366","author":"Y Jinsmaa","year":"2018","unstructured":"Jinsmaa Y, Sharabi Y, Sullivan P, Isonaka R, Goldstein DS. 3,4-Dihydroxyphenylacetaldehyde-induced protein modifications and their mitigation by N-acetylcysteine. J Pharmacol Exp Ther. 2018;366(1):113\u201324.","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"289_CR33","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s00401-019-02040-w","volume":"138","author":"N Van Den Berge","year":"2019","unstructured":"Van Den Berge N, Ferreira N, Gram H, Mikkelsen TW, Alstrup AKO, Casadei N, et al. Evidence for bidirectional and trans-synaptic parasympathetic and sympathetic propagation of alpha-synuclein in rats. Acta Neuropathol. 2019;138(4):535\u201350.","journal-title":"Acta Neuropathol"},{"issue":"3","key":"289_CR34","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3233\/JPD-171088","volume":"7","author":"CH Gibbons","year":"2017","unstructured":"Gibbons CH, Wang N, Freeman R. Cutaneous alpha-synuclein from paraffin embedded autopsy specimens in Parkinson\u2019s disease. J Parkinsons Dis. 2017;7(3):503\u20139.","journal-title":"J Parkinsons Dis"}],"container-title":["Translational Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40035-022-00289-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40035-022-00289-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40035-022-00289-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T14:09:18Z","timestamp":1646748558000},"score":1,"resource":{"primary":{"URL":"https:\/\/translationalneurodegeneration.biomedcentral.com\/articles\/10.1186\/s40035-022-00289-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,8]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["289"],"URL":"https:\/\/doi.org\/10.1186\/s40035-022-00289-y","relation":{},"ISSN":["2047-9158"],"issn-type":[{"value":"2047-9158","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,8]]},"assertion":[{"value":"2 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The NIH Office of Human Subjects Research Protections determined that this post-mortem study was exempt from the requirement of Institutional Review Board approval. Post-mortem tissues from clinically diagnosed and neuropathologically verified donors with PD as well as from controls were provided by the Banner Sun Health Research Institute (Sun City, AZ, USA) under an approved Material Transfer Agreement (MTA). At the\u00a0NIH, approval of an MTA requires clearance by the Ethics Office\u00a0of the relevant Institute. Informed consent for autopsy and the use of the tissues for scientific research was given by the next of kin.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors take full responsibility for the data, the analyses and interpretation, and the conduct of the research. The authors had full access to all of the data and have the right to publish any and all data separate and apart from any sponsor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All the authors have no relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15"}}